Status:
COMPLETED
Arterial Spin Labeling Perfusion Magnetic Resonance (MR) Imaging in Pediatric Brain Tumors
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
Thrasher Research Fund
Conditions:
Brain Tumors
Eligibility:
All Genders
Up to 18 years
Brief Summary
The purpose of this study is to get information regarding the usefulness and accuracy of this new magnetic resonance imaging (MRI) technique - termed arterial spin labeling (ASL) - in the diagnosis of...
Detailed Description
The purpose of this study is to get information regarding the usefulness and accuracy of this new MRI technique - termed arterial spin labeling (ASL) - in the diagnosis of pediatric brain tumors. This...
Eligibility Criteria
Inclusion
- Age 0-18 years
- Primary brain tumor (newly diagnosed or recurrent) with measurable disease (at least 1cm2)
Exclusion
- Patients with cardiac pacemaker or ferrous metal foreign bodies
- Patients with medical problems contradictive to receiving MRI scans.
- Patients requiring general anesthesia or sedation for their MRI scan.
- Patients with a history of cerebrovascular disorders (stroke, moya moya) that may alter cerebral perfusion.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00907244
Start Date
April 1 2008
End Date
July 1 2012
Last Update
October 29 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104